nwus 2008 conference agenda

8/14/2019 NWUS 2008 Conference Agenda

1/7

Northwest Urological Society 2008 AgendaFri Dec 5, 2008

Health Policy Agenda

8:00 Opening Remarks Tom Hatch, MDNWUS President

8:05 Getting Positive Results From your Contract NegotiationsNaya Keyhayes MPH

8:30 Employment Law Update for your PracticeJack Cooper JD

9:00 Panel Discussion moderated by Tom Hatch, MD

9:15 BREAK

9:30 Residency Training Programs and the Future of Urology RecruitmentJohn Barry MD AUA President

10:00 Legislative Issues Critical to Urology Jeff Kaufman MDAUA Health Policy Chair

AACU Past President

10:30 Panel Discussion moderator by Mark Uhlman, MDJohn Barry, MD (AUA President)Jeff Frankel, MD (AACU President-Elect)Jeff Kaufman, MD (AUA Health Policy Chair)

11:05 The Future of Medicine in America Dr. John Kitzhaber

Former Oregon State Governor11:45 Q & A

12:00 Lunch

Scientific Session Agenda

1:00 Opening Remarks Sia Daneshmand, MDNWUS Program Chair

1:05 Keynote Lecture:

Current role of BCG in the Management of Non-invasive Bladder Cancer Donald Lamm, M.D.

Vice Chair for Research Urologic OncologyDepartment of Urology, Mayo Clinic, Scottsdale, Arizona

1:45 ScientificSession I:

Oncology I

Podium 1-1 DOES THE ABILITY TO PERFORM RALP EXPAND THE POPULATION OF PATIENTSUNDERGOING SURGERY FOR THE MANAGEMENT OF PROSTATE CANCER?- Abtract # 837

Anthony J Woodruff MD, Erin M Odom MD andJohn M Corman MD, Seattle, WA


2/7

Podium 1-2 PT0 IS NOT BENIGN DISEASE: THERE IS A RISK OF PROGRESSION IN PATIENTS WITH NOCANCER IN RADICAL PROSTATECTOMY SPECIMENS- Abstract # 804Jennifer L. Gurski, Andrew C. Peterson MD, Timothy C. Brand MD. Madigan Army Medical Center, Tacoma, WA.

Podium 1-3 THE COMBINATION OF ANTISENSE OLIGONUCLEOTIDES TARGETING HEAT-SHOCKPROTEIN-27 WITH HTI-286 AS A NOVEL INTRAVESICAL TREATMENT FOR HIGH-GRADE BLADDER

CANCER- Abstract # 831Yoshiyuki Matsui, Boris A. Hadaschik MD, Martin E. Gleave MD and Alan I.SoMDThe Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada

Podium 1-4 PERIOPERATIVE MORTALITY FROM RADICAL CYSTECTOMY - A MODERN SERIES- Abstract#835Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 1-5 FACTORS INFLUENCING CHOICE OF URINARY DIVERSION FOLLOWING RADICALCYSTECTOMY- Abstract #826Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 1-6 AORTIC REPLACEMENT DURING POST-CHEMO RETROPERITONEAL LYMPH NODEDISSECTION- Abstract #841Sia Daneshmand, MD Section of Urologic Oncology, Division of Urology & Renal TransplantationOregon Health & Science University, Portland, OR

2:30 Break/ View Exhibits

3:00 Scientific Session II:

Endourology/ Minimally Invasive Surgery

Podium 2-1 IN-OFFICE LASER VAPORIZATION OF THE PROSTATE- Abstract #809Gregory B. McCoy, M.D., The Urology Clinic, Portland, Oregon

Podium 2-2 USE OF ANTEGRADE SALLE STENT IN LAPAROSCOPIC PYELOPLASTY- Abstract #810Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA

Podium 2-3 HOLMIUM LASER ENUCLEATION OF THE PROSTATE: MULTIMEDIA DESCRIPTION OFTECHNIQUE- Abstract #811Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA

Podium 2-4 PERCUTANEOUS RENAL CRYOABLATION: EARLY RESULTS FROM A PROSPECTIVEDATABASE- Abstract # 825CB Metcalfe MD, University of British Columbia Department of Urological Sciences. BJ Donnelly MD, Universityof Calgary Division of Urology. M Welsh MD, University of Calgary Department of Radiology

Podium 2-5 WHAT IS THE APPROPRIATE LENGTH OF URETERAL ACCESS SHEATH

FOR FLEXIBLE URETEROSCOPY?- Abstract #836Laura Chang Kit MD, Joel Teichman MD: University of British Columbia; Department of Urology, St PaulsHospital, Vancouver, BC Canada

Podium 2-6 REDUCTION OF STONE FRAGMENT RETROPULSION WITH ANTIRETROPULSION DEVICESAbstract #823

B. H. Chew MD, L.M.Jonat MD, R. F. Paterson, J. MD, M.H. Teichman MD: University of British Columbia,Vancouver, BC, Canada


3/7

Podium 2-7 URETEROSCOPIC LASER ENDOPAPILLOTOMY TO TREAT CHRONIC FLANK PAINASSOCIATED WITH PAPILLARY CALCIFICATIONS Abstract #813Yehoshua Gdor MD,Stephen Faddegon MD, Ahmed H. Gabr MD, William W. Roberts MD,Gary J. Faerber MD, Joel M.H. Teichman MD, J. Stuart Wolf M, Jr. MD

Department of Urology, University of Michigan, Ann Arbor, MI, USA;Dept. of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

Podium 2-8 INTRARENAL ULTRASOUND (IRUS) - A NOVEL TECHNOLOGY TO SIZE KIDNEY STONESDURING URETEROSCOPY- Abstract #802Mathew D. Sorensen, MD, MS, Michael R. Bailey, PhD: Department of Urology, University of Washington Schoolof Medicine, Seattle, WA

4:15 Point-Counter Point- Management of

High Grade T1 Bladder CancerDonald Lamm, M.D.- BCG

Sia Daneshmand, M.D.- Radical Cystectomy

Cases/Discussion

5:00 Adjourn


4/7

Saturday Dec 6, 2008

9:00 Scientific Session III:

Female Urology/Voiding Dysfunction

Podium 3-1 TRANSURETHRAL RADIOFREQUENCY COLLAGEN DENATURATION- Abstract #821Denise Elser, MDGK Mitchell, MD; JR Miklos, MD; KG Nickell, MD; K Cline, MD: H Winkler, MD; WG Wells, MD

Podium 3-2 DEFINING SUCCESS FOLLOWING SLING SURGERY: ASSOCIATION OF SATISFACTIONWITH PATIENT REPORTED OUTCOMES- Abstract #818

David E Rapp MD, Nancy J Neil MD,Alvaro Lucioni MD, Kathleen C Kobashi MDThe Continence Center at Virginia Mason Medical Center, Seattle, WA

Lifecycle Sciences Group, Icon Clinical Research, San Francisco, CA

Podium 3-3 PRE-OPERATIVE URODYNAMIC PARAMETERS DO NOT CORRELATE WITH RESPONSE TOBTX INJECTION IN PATIENTS WITH DETRUSOR OVERACTIVITY- Abstract #816

David E Rapp MD,Alvaro Lucioni MD, Jason Kim MD, W Stuart Reynolds MD, Kathleen C Kobashi MD,

Gregory T Bales MDThe Continence Center at Virginia Mason Medical Center, Seattle, WAThe University of Chicago Hospitals, Chicago, IL

Podium 3-4 OUTCOMES FOLLOWING MID-URETHRAL SLING PLACEMENT IN PATIENTS WITHINTRINSIC SPHINCTERIC DEFICIENCY: COMPARISON OF SPARC AND MONARC SLINGSAbstract #817

David E Rapp MD,Alvaro Lucioni MD, Fred E Govier MD, Kathleen C Kobashi MDThe Continence Center at Virginia Mason Medical Center, Seattle, WA

Podium 3-5 TEST-RETEST RELIABILITY OF REPEATED PRESSURE FLOW URODYNAMIC STUDIESDURING A SINGLE SESSION IN WOMEN- Abstract #815Justin Lee , Abhishek Seth MD, Ramon Geurro MD, Lynn Stothers MD: Department of Urological Science,University of British Columbia, Vancouver, BC

9:45 Scientific Session IV:

Pediatrics

Podium 4-1 THE USE OF PATIENT-ACQUIRED DIGITAL IMAGES FOR POSTOPERATIVE CAREAbstract #828Van Ginger MD, Thomas Lendvay MD, Byron Joyner MD, Martin Koyle MD: Childrens Hospital & RegionalMedical Center, Seattle, WA

Podium 4-2 PROGNOSTIC FACTORS IN RESOLUTION OF ANTENATALLY DIAGNOSEDHYDRONEPHROSIS: A MULTIVARIABLE ANALYSIS- Abstract #824

M. Longpre MD, D. Yanko MD, S. Jafari MD, K. Afshar MDUniversity of British Columbia

Podium 4-3 TECHNIQUE OF UMBILICAL RECONSTRUCTION USING A TWO-FACED FLAP TECHNIQUEAbstract #807Stephanya Shear, MD MPH, Byron Joyner, M.D., Margarett Shnorhavorian, M.D., M.P.H., Thomas Lendvay,M.D., Martin Koyle, M.D.Richard. W. Grady, M.D.: Childrens Hospital & Regional Medical Center, Seattle, WA


5/7

Podium 4-4 URODYNAMIC PROFILE FINDINGS FOLLOWING BLADDER AUTOAUGMENTATIONAbstract #808

Jennifer Foti MD, Ismael Zamilpa MD, Thomas Lendvay MD, Richard Grady MDChildren's Hospital and Regional Medical Center; Seattle, Washington

10:15 Scientific Session V:

Transplant/Infertiltiy

Podium 5-1 GRAFT AND CORRUPTION - THE USE OF ARTIFICIAL VASCULAR GRAFTSIN KIDNEY TRANSPLANTATION- Abstract #830Christian S. Kuhr MD and Thomas R. Hefty MD: Virginia Mason Medical Center, Seattle, WA

Podium 5-2 PREDICTION OF DELAYED GRAFT FUNCTION (DGF) AFTER DECESASED-DONOR RENALTRANSPLANTATION- Abstract #820Jason C. Hedges, M.D., Ph.D., J. C. Prather, Ph.D., John M. Barry, M.D.Division of Urology & Renal Transplantation, Oregon Health & Science University

Podium 5-3 DURING VASECTOMY REVERSAL SURGERY, THE PROBABILITY OF EPIDIDYMAL BYPASS

RATHER THAN VASOVASOSTOMY INCREASES AS TIME FROM VASECTOMY LENGTHENS- Abstract#805Gregory S. Taylor M.D.,Molly E. Fuchs, B.A., Lisa B. Bland, M.D., M.P.H., Eugene F. Fuchs M.D.: Oregon Health& Science University

Podium 5-4 DURING VASECTOMY REVERSAL, FINDING ONLY SPERM HEADS IN PROXIMAL VASFLUID PREDICTS TECHNICAL SUCCESS- Abstract #806Lisa B. Bland, M.D., M.P.H., Molly E. Fuchs, B.A.*, Eugene F. Fuchs, M.D.: Oregon Health & Science University

10:45 Break/ Exhibit Hall

11:15 State of the Art Lecture:

Robotic Renal SurgerySam Bhayani, M.D., Co-Director of Robotic Surgery, Assistant Professor of Urology and Surgery, WashingtonUniversity School of Medicine, St. Louis, MO

12:00 Lunch

1:00 Scientific Session VI:

Oncology II

Podium 6-1 TIME TO TREATMENT OF PROSTATE CANCER THROUGH THE CALGARY PROSTATEINSTITUTE RAPID ACCESS CLINIC- Abstract #822A.G Kavanagh MD, J.C. Lee MD, B. Donnelly MD, University of Calgary

Podium 6-2 ARE ROUTINE METASTATIC SURVEYS WARRANTED FOR INTERMEDIATE RISK PROSTATECANCER? Abstract #819

Andrew Locke, Erin Odom andJohn M. Corman, M.D.: Virginia Mason Medical Center, Seattle, WA

Podium 6-3 TRANSURETHRAL PROSTATE BIOPSY FOR CANCER DETECTIONIN PATIENTS UNDERGOING SERIAL BIOPSIES- Abstract #833


6/7

Gregory T. Adams MD, Gregory S. Rosenblatt MD, Shane Rogosin MD, Solange Mongoue-Tchokote MS, MarkGarzotto, MD; Oregon Health & Science University, Portland, OR.

Podium 6-4 DIFFERENTIAL TARGET IDENTIFICATION OF STATIN THERAPY IN ANDROGEN SENSITIVE AND INSENSITIVE PROSTATE CANCER CELLS- Abstract #834Mark Garzotto MD, Nicole M. Janeba B.A and Jackilen Shannon PhD.Oregon Health & Science University, Portland, OR.

Podium 6-5 EFFECT OF OBESITY ON PSA DENSITY: IMPLICATIONS FOR IMPROVED DETECTION OFPROSTATE CANCER- Abstract #832Maire Brennan MS, Solange Mongoue-Tchokote PhD, Jackilen Shannon PhD, Motomi Mori, and Mark GarzottoMD. Oregon Health & Science University, Portland OR.

Podium 6-6 PHASE I TRIAL OF IPILIMUMAB (IPI) ALONE AND IN COMBINATION WITHRADIOTHERAPY (XRT) IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATECANCER (MCRPC)- Abstract #829TM Beer,1 SF Slovin,2 CS Higano,3 S Tejwani,4 TB Dorff,5 HI Scher,2 I Lowy,6and the Prostate Cancer ClinicalTrials Consortium. 1Oregon Health & Science University, 2Memorial Sloan Kettering Cancer Center, 3University ofWashington, 4Henry Ford Health System, 5The Angeles Clinic and Research Institute, 6Medarex, Inc.

Podium 6-7 DAVINCI PROSTATECTOMY: RESULTS FROM 500 CONSECUTIVE PATIENTS- Abstract # 840

James Porter MD andUzay Yasar MD, Swedish Urology Group, Seattle, WA

Podium 6-8 ROBOTIC PARTIAL NEPHRECTOMY- Abstract # 839James Porter, MD ,Swedish Urology Group, Seattle, WA

1:55 Guest Lecture:

CT Urography -- Imaging the patient with painless hematuriaLarry Chow, M.D.,Associate Professor of Radiology, Oregon Health & Science University

2:30 Break/Exhibit Hall

3:00 Scientific Session VII:Miscellaneous

Podium 7-1 THE ADULT TEMPLATE CIRCUMCISION: A NOVEL TECHNIQUE- Abstract #803Jennifer L. Gurski MD, Brian J. DeCastro MD, Andrew C. Peterson MDMadigan Army Medical Center, Tacoma, WA.

Podium 7-2 USE OF AN OMENTAL WRAP IN URETEROLYSIS- Abstract #801Jason P. Smith, M.D., Eric Reid, M.D., Aaron Bayne, M.D., Stephen Dunn, M.D., Thomas Hatch, M.D.Oregon Health and Sciences University

Portland VA Medical Center

Podium 7-3 APPENDICEAL SUBSTITUTION FOLLOWING RIGHT PROXIMAL URETER INJURY

Abstract #827Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 7-4 EVALUATION AND TREATMENT OF LOIN PAIN HEMATURIA SYNDROME- Abstract #812Eric S. Reid, MD and John M. Barry, MD: Division of Urology and Renal Transplantation, Portland, OR

Podium 7-5 HUGH HAMPTON YOUNG: FOREFATHER OF AMERICAN UROLOGIC SURGERYAbstract #814Brian Duty, M.D. Division of Urology & Renal Transplantation, Oregon Health & Science University


7/7

3:30 Management of Clinical Stage I Testis Cancer in 2008-Craig Nichols, M.D., Director, Providence Cancer Center

4:00 Keynote Speaker:

Management of Patients with BCG Failure Donald Lamm, M.D.Vice Chair for Research Urologic Oncology

Department of Urology, Mayo ClinicScottsdale, Arizona

4:30 Interactive Case Discussions

5:00 Adjourn

nwus 2008 conference agenda

Documents